These emerging treatments, Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and conceivably associated disorders. They all are classified as GLP-1 pathway activators , signifying they to mimic the endogenous GLP-1 peptide, boosting glucose secretion and suppressing appetite . While Tirzepatide each one functi… Read More